Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

1

IJMRHS. 2013; 2(4): 917-922


Preventive measures needed for long term use of carbamazepine to lower the risk for coronary heart disease

Paunipagar Prashant V, Babu Ramesh B, Sharma Rahul P.

Abstract
Present cross sectional study was carried out with a view to evaluate the Carbamazepine risk for coronary heart disease. Lipid profile and Framingham point scores were studied in 60 Epilepsy patients on Carbamazepine. The epileptic patients were compared with age and sex matched 60 healthy controls. Framingham Point Scores were estimated by taking into consideration several parameters i.e. Age, Sex, Systolic blood pressure, HDL levels, Total cholesterol, and smoking history, as per guidelines of the Framingham Heart Study group We conclude that this drug significantly increases the risk for coronary heart disease in patients with respect to lipid profile and other parameters as described by the Framingham study group. Altogether, this drug may be one of the reasons for the high prevalence of CHD, which is increasing day-by-day due to the globalization.

Key words: Carbamazepine, Epilepsy, Lipid Profile, Coronary heart disease



Share this Article


Advertisement
Journal of Apitherapy

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons